Abstract
Background: Appendiceal carcinoids (AC) are usually adequately treated by appendectomy. The European Neuroendocrine Tumours Society (ENETS) has recently reconsidered the previous pathologic criteria to identify patients at high risk of extra-appendiceal disease, who are thought to require right hemicolectomy (RHC). Aim: The aim of this retrospective, observational study was to evaluate previous and currently introduced criteria, in identifying patients with AC in whom RHC is justified. Subjects and methods: Twelve patients who underwent RHC for AC were retrospectively identified. Demographic and follow-up data were collected and appendectomy specimens were reviewed for the presence of indications leading to RHC defined as: tumor diameter ≥2 cm, tumor location at the base, mesoappendiceal extension, mitotic index Ki-67≥2%. RHC specimens were examined to identify evidence of extra-appendiceal disease, remaining and/or metastatic disease. Results: Four patients fulfilled two criteria and 8 one criterion for RHC. Two patients had tumors ≥2.0 cm, 5 located at the base, 8 invading the mesoappendix and periappendiceal fat; Ki-67 PI was 1% in all cases measured except one, in which it was 3%. Post-RHC, 3 patients (25%) had extra-appendiceal disease (no residual disease was identified in surgical margins); 1 had tumor at the colon specimen and 2 had lymph node metastasis. All 3 patients fulfilled only one pathologic criterion; 1 had tumor mesoappendiceal extension and 2 tumor location at the base of the appendix. Conclusions: Applying previous and currently introduced pathologic criteria, 25% of high-risk patients with AC had identifiable extra-appendiceal disease following RHC that might be not detected following the recently introduced ENETS criteria.
Similar content being viewed by others
References
Moertel CG, Dockerty MB, Judd ES. Carcinoid tumors of the vermiform appendix. Cancer 1968, 21: 270–8.
Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999, 340: 858–68.
Plöckinger U, Couvelard A, Falconi M, et al; Frascati Consensus Conference participants. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinology 2008, 87: 20–30.
Syracuse DC, Perzin KH, Price JB, Wiedel PD, Mesa-Tejada R. Carcinoid tumors of the appendix: mesoappendiceal extension and nodal metastases. Ann Surg 1979, 190: 58–63.
Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiological study from Sweden. Cancer 2001, 92: 2204–10.
McCusker ME, Coté TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program 1973–1998. Cancer 2002, 94: 3307–12.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumours. Cancer 2003, 97: 934–59.
Fornaro R, Frascio M, Sticchi C, et al. Appendectomy or right hemicolectomy in the treatment of appendiceal carcinoid tumors? Tumori 2007, 93: 587–90.
In’t Hof KH, van der Wal HC, Kazemier G, Lange JF. Carcinoid tumour of the appendix: an analysis of 1,485 consecutive emergency appendectomies. J Gastrointest Surg 2008, 12: 1436–8.
Butte JM, García-Huidobro MA, Torres J, Duarte I, Zúñiga A, Llanos O. Long-term survival in carcionoid tumour of the appendix. An analysis of 8903 appendectomies. Gastroenterol Hepatol 2009, 32: 537–41.
Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 1987, 317: 1699–701.
Goede AC, Caplin ME, Winslet MC. Carcinoid tumour of the appendix. Br J Surg 2003, 90: 1317–22.
Anderson JR, Wilson BG. Carcinoid tumours of the appendix. Br J Surg 1985, 72: 545–6.
Dent TL, Batsakis JG, Lindenauer SM. Carcinoid tumors of the appendix. Surgery 1973, 73: 828–32.
McGory ML, Maggard MA, Kang H, O’Connell JB, Ko CY. Malignancies of the appendix: beyond case series reports. Dis Colon Rectum 2005, 48: 2264–71.
Bamboat ZM, Berger DL. Is right hemicolectomy for 2.0-cm appendiceal carcinoids justified? Arch Surg 2006, 141: 349–52.
Thompson GB, van Heerden JA, Martin JK Jr, Schutt AJ, Ilstrup DM, Carney JA. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985, 98: 1054–63.
Gouzi JL, Laigneau P, Delalande JP, et al. Indications for right hemicolectomy in carcinoid tumors of the appendix The French Associations for Surgical Research. Surg Gynecol Obstet 1993, 176: 543–7.
Beyrouti MI, Gharbi A, Abid M, et al. Carcinoid tumors of the appendix. A report of 46 cases. Tunis Med 2004, 82: 668–73.
Guraya SY, Khairy GA, Ghallab A, Al-Saigh A. Carcinoid tumors of the appendix. Our experience in a university hospital. Saudi Med J 2005, 26: 434–7.
Safioleas MC, Moulakakis KG, Kontzoglou K, et al. Carcinoid tumors of the appendix. Prognostic factors and evaluation of indications for right hemicolectomy. Hepatogastroenterology 2005, 52: 123–7.
Toumpanakis C, Standish RA, Baishnab E, Winslet MC, Caplin ME. Goblet cell carcinoid tumors (adenocarcinoid) of the appendix. Dis Colon Rectum 2007, 50: 315–22.
Klöppel G, Couvelard A, Perren A, et al; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009, 90: 162–6.
Bowman GA, Rosenthal D. Carcinoid tumors of the appendix. Am J Surg 1983, 146: 700–3.
Roggo A, Wood WC, Ottinger LW. Carcinoid tumors of the appendix. Ann Surg 1993, 217: 385–90.
Svendsen LB, Bülow S. Carcinoid tumours of the appendix in young patients. Acta Chir Scand 1980, 146: 137–9.
Rindi G, Klöppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007, 451: 757–62.
Berardi RS, Lee SS, Chen HP. Goblet cell carcinoids of the appendix. Surg Gynecol Obstet 1988, 167: 81–6.
Butler JA, Houshiar A, Lin F, Wilson SE. Goblet cell carcinoid of the appendix. Am J Surg 1994, 168: 685–7.
Sökmensüer C, Gedikoglu G, Uzunalimoglu B. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study. Hepatogastroenterology 2001, 48: 720–3.
Kawahara M, Kammori M, Kanauchi H, et al. Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours. Eur J Surg Oncol 2002, 28: 140–6.
Stinner B, Rothmund M. Neuroendocrine tumours (carcinoids) of the appendix. Best Best Pract Res Clin Gastroenterol 2005, 19: 729–38.
de Herder WW. Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007, 21: 33–41.
Cwikea JB, Buscombe JR, Caplin ME, et al. Diagnostic imaging of carcinoid metastases to the abdomen and pelvis. Med Sci Monit 2004, 10 (Suppl 3): 9–16.
Oberg K, Eriksson B. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. Best Pract Res Clin Endocrinol Metab 2005, 19: 265–76.
Dillman RO, Aaron K, Heinemann FS, McClure SE. Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer 2009, 115: 1840–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alexandraki, K.I., Griniatsos, J., Bramis, K.I. et al. Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria. J Endocrinol Invest 34, 255–259 (2011). https://doi.org/10.1007/BF03347081
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347081